Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04753489
Status:
UNKNOWN
Last Update Posted:
2021-02-15
First Post:
2021-02-10
Brief Title:
Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Conditions
Sponsor:
Pharmtechnology LLC
Organization:
Pharmtechnology LLC
Organization Data
Organization:
Pharmtechnology LLC
Class:
INDUSTRY
Study ID:
RVRX_10-2020-CPD-FRMT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pharmtechnology LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ClinPharmInvest LLC | OTHER |